Literature DB >> 28130813

Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.

Leon A Sakkal1, Kyle Z Rajkowski1, Roger S Armen1.   

Abstract

Following insights from recent crystal structures of the muscarinic acetylcholine receptor, binding modes of Positive Allosteric Modulators (PAMs) were predicted under the assumption that PAMs should bind to the extracellular surface of the active state. A series of well-characterized PAMs for adenosine (A1 R, A2A R, A3 R) and muscarinic acetylcholine (M1 R, M5 R) receptors were modeled using both rigid and flexible receptor CHARMM-based molecular docking. Studies of adenosine receptors investigated the molecular basis of the probe-dependence of PAM activity by modeling in complex with specific agonist radioligands. Consensus binding modes map common pharmacophore features of several chemical series to specific binding interactions. These models provide a rationalization of how PAM binding slows agonist radioligand dissociation kinetics. M1 R PAMs were predicted to bind in the analogous M2 R PAM LY2119620 binding site. The M5 R NAM (ML-375) was predicted to bind in the PAM (ML-380) binding site with a unique induced-fit receptor conformation.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cl-IB-MECA; LUF6000; MRS-542; inosine; ischemic

Mesh:

Substances:

Year:  2017        PMID: 28130813      PMCID: PMC5403616          DOI: 10.1002/jcc.24728

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  101 in total

Review 1.  The pharmacological properties of tiotropium.

Authors:  P J Barnes
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

2.  Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.

Authors:  M Wienrich; D Meier; H A Ensinger; W Gaida; A Raschig; A Walland; R Hammer
Journal:  Life Sci       Date:  2001-04-27       Impact factor: 5.037

3.  Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.

Authors:  Ron O Dror; Hillary F Green; Celine Valant; David W Borhani; James R Valcourt; Albert C Pan; Daniel H Arlow; Meritxell Canals; J Robert Lane; Raphaël Rahmani; Jonathan B Baell; Patrick M Sexton; Arthur Christopoulos; David E Shaw
Journal:  Nature       Date:  2013-10-13       Impact factor: 49.962

4.  The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor.

Authors:  J Robert Lane; Margot W Beukers; Thea Mulder-Krieger; Ad P Ijzerman
Journal:  Biochem Pharmacol       Date:  2009-08-07       Impact factor: 5.858

Review 5.  Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.

Authors:  Klaus Mohr; Jens Schmitz; Ramona Schrage; Christian Tränkle; Ulrike Holzgrabe
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-06       Impact factor: 15.336

6.  Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.

Authors:  Rodrigo Medeiros; Masashi Kitazawa; Antonella Caccamo; David Baglietto-Vargas; Tatiana Estrada-Hernandez; David H Cribbs; Avraham Fisher; Frank M LaFerla
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

7.  Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.

Authors:  R F Bruns; J H Fergus; L L Coughenour; G G Courtland; T A Pugsley; J H Dodd; F J Tinney
Journal:  Mol Pharmacol       Date:  1990-12       Impact factor: 4.436

8.  Protective effect of cyclohexyladenosine on adenosine A1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study.

Authors:  J L Daval; D K Von Lubitz; J Deckert; D J Redmond; P J Marangos
Journal:  Brain Res       Date:  1989-07-10       Impact factor: 3.252

9.  Propagation of conformational changes during μ-opioid receptor activation.

Authors:  Rémy Sounier; Camille Mas; Jan Steyaert; Toon Laeremans; Aashish Manglik; Weijiao Huang; Brian K Kobilka; Héléne Déméné; Sébastien Granier
Journal:  Nature       Date:  2015-08-05       Impact factor: 49.962

10.  Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Carlota Lopez Cara; Olga Cruz-Lopez; Maria Antonietta Iaconinoto; Delia Preti; John C Shryock; Allan R Moorman; Fabrizio Vincenzi; Katia Varani; Pier Andrea Borea
Journal:  J Med Chem       Date:  2008-08-26       Impact factor: 7.446

View more
  1 in total

1.  A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation.

Authors:  Tung O Chan; Roger S Armen; Santosh Yadav; Sushrut Shah; Jin Zhang; Brian C Tiegs; Nikhil Keny; Brian Blumhof; Deepak A Deshpande; Ulrich Rodeck; Raymond B Penn
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.